Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Harvard Bioscience, Inc. - Common Stock (NQ:HBIO)

0.5297 +0.0407 (+8.32%)
Streaming Delayed Price Updated: 10:55 AM EDT, Aug 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Harvard Bioscience, Inc. - Common Stock

< Previous 1 2 3 Next >
Harvard Bioscience Inc (NASDAQ:HBIO) Reports Mixed Q2 2025 Earnings Amid Revenue Miss and Improved Cash Flow
Harvard Bioscience (HBIO) reported mixed Q2 2025 results, missing revenue estimates but matching EPS. Improved cash flow and cost control offset weak sales, with stock up 18.7% pre-earnings. 
Via Chartmill
Harvard Bioscience Tops Q2 Revenue Views
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Which stocks are moving on Monday?
Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
Earnings Scheduled For May 12, 2025
 
Via Benzinga
A Preview Of Harvard Bioscience's Earnings
 
Via Benzinga
Earnings Scheduled For August 11, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Wondering what's happening in today's after-hours session?
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
Which stocks are experiencing notable movement on Friday?
Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Top movers in Friday's session
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
Top movers in Friday's pre-market session
The US market session of Friday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
What's going on in today's after hours session
After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
Via Chartmill
Which stocks are most active on Thursday?
Discover the most active stocks in Thursday's session. Stay informed about the stocks that are generating the most trading volume! 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Get insights into the top gainers and losers of Wednesday's after-hours session.
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Examining the Future: Harvard Bioscience's Earnings Outlook
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Traders are paying attention to the gapping stocks in Tuesday's session.
Let's have a look at the gap up and gap down stocks in today's session. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Earnings Scheduled For March 12, 2025
 
Via Benzinga
HBIO Stock Earnings: Harvard Bioscience Misses Revenue for Q2 2024
HBIO stock results show that Harvard Bioscience missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Holley And 2 Other Stocks Under $5 Insiders Are Buying
 
Via Benzinga
FlexShopper And 3 Other Stocks Under $5 Insiders Are Buying
 
Via Benzinga
HBIO Stock Earnings: Harvard Bioscience Meets EPS, Misses Revenue for Q1 2024
HBIO stock results show that Harvard Bioscience met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
HBIO Stock Earnings: Harvard Bioscience Misses EPS, Misses Revenue for Q4 2023
HBIO stock results show that Harvard Bioscience missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Earnings Scheduled For March 7, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.